Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Catalent, Inc.CTLT · Entity 16279 | President, CSS | January 21, 2022 | January 24, 2022 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Operating Officer | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Catalent, Inc.
Report date January 21, 2022 · Filed January 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,923 |
Reported balance
After 2022-01-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-01-21 · Sale · Disposed 184 · Balance 2,923 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by, or surrendered to, the Issuer. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by, or surrendered to, the Issuer.
F2: Includes restricted stock units.
MIMEDX GROUP, INC.
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 462,825 |
Reported balance
After 2026-03-04 transaction · row 1
1 source rowRow 1 · 2026-03-04 · Grant · Acquired 74,163 · Balance 462,825 F1: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $5.10 · Expires 2033-03-03 | Direct | 169,309 |
Reported balance
After 2026-03-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-04 · Grant · Acquired 62,068 · Balance 169,309 F2: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F2: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 22:43 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 62,068 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001798744-26-000006 · wk-form4_1772837004.xml · derivative · entry 2 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,309 Underlying: Common Stock · 62,068 shares Expires 2033-03-03 F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:43 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 74,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001798744-26-000006 · wk-form4_1772837004.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,825 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 23:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 61,961 | $5.12 | $317,240.32 |
DisclosureSEC source: 0001798744-26-000003 · wk-form4_1771456386.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,662 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. F2 · balance_after: Includes an aggregate of 1,675 shares acquired on July 31, 2025 and January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:03 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 36,486 | $0.00 Strike: $8.30 | $0.00 |
DisclosureSEC source: 0001376339-25-000023 · wk-form4_1741219382.xml · derivative · entry 2 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,241 Underlying: Common Stock · 36,486 shares Expires 2032-03-03 F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:03 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 45,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-25-000023 · wk-form4_1741219382.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,948 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:36 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 61,420 | $8.28 | $508,557.60 |
DisclosureSEC source: 0001376339-25-000002 · wk-form4_1739918208.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,019 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · balance_after: Includes an aggregate of 4,911 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 70,755 | $0.00 Strike: $8.63 | $0.00 |
DisclosureSEC source: 0001376339-24-000016 · wk-form4_1709681249.xml · derivative · entry 2 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,755 Underlying: Common Stock · 70,755 shares Expires 2031-03-01 F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 58,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-24-000016 · wk-form4_1709681249.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,528 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:40 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 15,271 | $8.01 | $122,351.25 |
DisclosureSEC source: 0001376339-24-000004 · wk-form4_1708551614.xml · nonDerivative · entry 2 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,050 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:40 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 15,493 | $8.07 | $125,074.99 |
DisclosureSEC source: 0001376339-24-000004 · wk-form4_1708551614.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,321 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 15,198 | $8.06 | $122,495.88 |
DisclosureSEC source: 0001376339-24-000002 · wk-form4_1708118497.xml · nonDerivative · entry 2 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,814 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 15,845 | $8.03 | $127,267.04 |
DisclosureSEC source: 0001376339-24-000002 · wk-form4_1708118497.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,012 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 13, 2023 Filed Mar 15, 2023 22:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 462,857 | $3.50 | $1,619,999.50 |
DisclosureSEC source: 0001798744-23-000004 · wf-form4_167891840398121.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,857 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| January 21, 2022 Filed Jan 24, 2022 16:42 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 184 | $102.37 | $18,836.08 |
DisclosureSEC source: 0001596783-22-000016 · wf-form4_164306054715818.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,923 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by, or surrendered to, the Issuer. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 16:30 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 2,748 | $0.00 Strike: $113.00 | $0.00 |
DisclosureSEC source: 0001596783-21-000101 · wf-form4_162750417959158.xml · derivative · entry 2 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,748 Underlying: Common Stock · 2,748 shares Expires 2031-07-26 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 26, 2022. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 16:30 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-21-000101 · wf-form4_162750417959158.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,107 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 21, 2021 Filed Jan 25, 2021 07:17 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 692 | $118.85 | $82,244.20 |
DisclosureSEC source: 0001596783-21-000028 · wf-form4_161157706144617.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:47 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 83 | $104.42 | $8,666.86 |
DisclosureSEC source: 0001596783-21-000022 · wf-form4_160990122596669.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,268 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $104.30 to $104.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 12:03 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 3,510 | $0.00 Strike: $88.10 | $0.00 |
DisclosureSEC source: 0001596783-20-000122 · wf-form4_159647060681124.xml · derivative · entry 2 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,510 Underlying: Common Stock · 3,510 shares Expires 2030-07-30 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 30, 2021. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 12:03 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 647 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000122 · wf-form4_159647060681124.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,351 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 12:22 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 240 | $56.46 | $13,550.40 |
DisclosureSEC source: 0001596783-20-000045 · wf-form4_158679493359143.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704 F1 · shares: Restricted stock units (RSUs) received in lieu of reporting person's receipt of certain other compensation. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on December 31, 2020. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 20, 2020 Filed Jan 21, 2020 10:53 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000008 · wf-form4_157962200560137.xml · nonDerivative · entry 1 Whitlow Ricci S · CIK 0001798744 · President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,464 F1 · shares: Restricted stock units (RSUs) received by the reporting person under the Issuer's omnibus incentive plan in connection with reporting person's election as an executive officer of Issuer. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur as to 75% and 25% of the RSUs on each of the first two anniversaries of the grant date, respectively. F2 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.